SUBSCRIBE
SUBSCRIBE

Hematology

vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Lymphoma
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result “doesn’t waver our optimism” regarding the bispecific antibody’s ongoing frontline trial.
January 19, 2026
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
June 8, 2026
 · 
4 min read
Press Releases
Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin’s Annamycin in Relapsed/Refractory AML
June 5, 2026
 · 
8 min read
Press Releases
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
June 5, 2026
 · 
3 min read
Press Releases
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
June 4, 2026
 · 
9 min read
Press Releases
Alex “A-Rod” Rodriguez to Deliver Special Remarks at The Foundation for Sickle Cell Disease Research’s 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting
June 4, 2026
 · 
3 min read
Press Releases
Lupeng Pharmaceutical’s Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
June 4, 2026
 · 
6 min read
Press Releases
Taiho Oncology Announces New England Journal of Medicine Publication of First All-Oral Regimen in Newly Diagnosed Acute Myeloid Leukemia
June 4, 2026
 · 
7 min read
Press Releases
Blood Cancer Treatment Allows Hard-to-Match Kidney Failure Patients to Receive a Compatible Kidney Transplant
June 4, 2026
 · 
7 min read
Press Releases
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
June 4, 2026
 · 
10 min read
Press Releases
Mission Bio’s Tapestri Enables Single-Cell Profiling of Residual Disease, Identifying AML Patients Likely to Benefit from Motixafortide in the Multicenter BLAST Trial
June 4, 2026
 · 
5 min read
Press Releases
Ryan Clark to Deliver Warrior Keynote at The Foundation for Sickle Cell Disease Research’s 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting
June 3, 2026
 · 
3 min read
Press Releases
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
June 3, 2026
 · 
7 min read
Press Releases
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 1, 2026
June 1, 2026
 · 
1 min read
Press Releases
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
June 1, 2026
 · 
1 min read
Press Releases
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
June 1, 2026
 · 
19 min read
Press Releases
BioInvent to Host a KOL Event in Stockholm on June 11, 2026, to Discuss Updated BI-1206 & BI-1808 Data in Hematology
June 1, 2026
 · 
7 min read
Press Releases
Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib
June 1, 2026
 · 
12 min read
Press Releases
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
June 1, 2026
 · 
13 min read
Press Releases
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
May 29, 2026
 · 
19 min read
Press Releases
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
May 28, 2026
 · 
5 min read
Load More